CALCIUM ACETATE capsule Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium acetate capsule

nostrum laboratories, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium a

CALCIUM ACETATE capsule Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium acetate capsule

state of florida doh central pharmacy - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate gelcaps is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate gelcaps contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

CALCIUM ACETATE 667 MG- calcium acetate tablet, coated Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium acetate 667 mg- calcium acetate tablet, coated

pharmin usa, llc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd).

CALCIUM ACETATE capsule Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium acetate capsule

sandoz inc - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate gelcaps is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate gelcaps contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions ( 5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. calcium acetate is excreted in human milk. human milk feeding by a mother receiving calcium acetate is not expected to harm an infant, provided maternal serum calcium levels are appropriately monitored. safety and effectiveness in pediatric patients have not been established. clinical studies of calcium acetate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

CALCIUM - D - SOURCE Israel - englanti - Ministry of Health

calcium - d - source

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Calcium As Calcium Gluconate Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

calcium as calcium gluconate

vetoquinol australia pty ltd - calcium as calcium gluconate - unknown - calcium as calcium gluconate mineral-calcium-salt active 0.0 - active constituent

Calcium-Sandoz Forte 500 mg, effervescent tablets Malta - englanti - Malta Medicines Authority

calcium-sandoz forte 500 mg, effervescent tablets

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - calcium, calcium carbonate, calcium lactate - effervescent tablet - calcium 500 mg calcium carbonate 300 mg calcium lactate - mineral supplements

CALCIUM GLUCONATE - calcium gluconate injection, solution Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium gluconate - calcium gluconate injection, solution

american regent, inc. - calcium gluconate monohydrate (unii: czn0mi5r31) (calcium - unii:sy7q814vup) - calcium gluconate is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy. it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage. calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs. in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia. intravenous administration of calcium is contraindicated when serum calcium levels are above normal. if neonates are required, or expected to require, trea

CALCIUM ACETATE- calcium acetate capsule Yhdysvallat - englanti - NLM (National Library of Medicine)

calcium acetate- calcium acetate capsule

remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate, usp is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). - patients with hypercalcemia. patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acet

SWICAL EXTRA-FORT TABLET Kanada - englanti - Health Canada

swical extra-fort tablet

les laboratoires suisse inc. - calcium (calcium carbonate, calcium citrate, calcium phosphate); magnesium (magnesium citrate, magnesium oxide); vitamin d3; phosphorus (calcium phosphate); silicon (silicon dioxide); zinc (zinc gluconate); fluorine (calcium fluoride) - tablet - 600mg; 100mg; 200unit; 100mg; 5mg; 5mg; 0.05mg - calcium (calcium carbonate, calcium citrate, calcium phosphate) 600mg; magnesium (magnesium citrate, magnesium oxide) 100mg; vitamin d3 200unit; phosphorus (calcium phosphate) 100mg; silicon (silicon dioxide) 5mg; zinc (zinc gluconate) 5mg; fluorine (calcium fluoride) 0.05mg